70 related articles for article (PubMed ID: 28207102)
1. Real-time reverse-transcription PCR to quantify a panel of 19 genes in breast cancer: relationships with sentinel lymph node invasion.
Revillion F; Lhotellier V; Hornez L; Leroy A; Baranzelli MC; Giard S; Bonneterre J; Peyrat JP
Int J Biol Markers; 2008; 23(1):10-17. PubMed ID: 28207102
[TBL] [Abstract][Full Text] [Related]
2. Real-time reverse-transcription PCR to quantify a panel of 19 genes in breast cancer: relationships with sentinel lymph node invasion.
Révillion F; Lhotellier V; Hornez L; Leroy A; Baranzelli MC; Giard S; Bonneterre J; Peyrat JP
Int J Biol Markers; 2008; 23(1):10-7. PubMed ID: 18409145
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients.
Kwon Y; Ro J; Kang HS; Kim SK; Hong EK; Khang SK; Gong G; Ro JY
Oncol Rep; 2011 Apr; 25(4):1063-71. PubMed ID: 21258771
[TBL] [Abstract][Full Text] [Related]
4. One Step Nucleic Acid Amplification (OSNA) positive micrometastases and additional histopathological NSLN metastases: Results from a single institution over 53 months.
Babar M; Madani R; Jackson P; Layer GT; Kissin MW; Irvine TE
Surgeon; 2016 Apr; 14(2):76-81. PubMed ID: 25444440
[TBL] [Abstract][Full Text] [Related]
5. Primary breast cancer features can predict additional lymph node involvement in patients with sentinel node micrometastases.
Carcoforo P; Maestroni U; Querzoli P; Lanzara S; Maravegias K; Feggi L; Soliani G; Basaglia E
World J Surg; 2006 Sep; 30(9):1653-7. PubMed ID: 16927059
[TBL] [Abstract][Full Text] [Related]
6. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
[TBL] [Abstract][Full Text] [Related]
7. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
8. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.
Gimbergues P; Dauplat MM; Cayre A; Durando X; Le Bouedec G; Finat-Duclos F; Portefaix G; Kwiatkowski F; Dauplat J; Penault-Llorca F; Tchirkov A
Eur J Surg Oncol; 2007 Feb; 33(1):16-22. PubMed ID: 17071045
[TBL] [Abstract][Full Text] [Related]
9. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
[TBL] [Abstract][Full Text] [Related]
10. The Sentinel Node with Isolated Breast Tumor Cells or Micrometastases. Benefits and Risks of Axillary Dissection.
Madekivi V; Boström P; Aaltonen R; Vahlberg T; Salminen E
Anticancer Res; 2017 Jul; 37(7):3757-3762. PubMed ID: 28668871
[TBL] [Abstract][Full Text] [Related]
11. Factors predicting the non-sentinel lymph node involvement in breast cancer patients with sentinel lymph node metastases.
Boler DE; Uras C; Ince U; Cabioglu N
Breast; 2012 Aug; 21(4):518-23. PubMed ID: 22410110
[TBL] [Abstract][Full Text] [Related]
12. Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer.
Ozmen V; Karanlik H; Cabioglu N; Igci A; Kecer M; Asoglu O; Tuzlali S; Mudun A
Breast Cancer Res Treat; 2006 Jan; 95(1):1-6. PubMed ID: 16322900
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the histological size of the sentinel lymph node metastases using RT-PCR assay: a rapid tool to estimate the risk of non-sentinel lymph node invasion in patients with breast cancer.
Veys I; Majjaj S; Salgado R; Noterman D; Schobbens JC; Manouach F; Bourgeois P; Nogaret JM; Larsimont D; Durbecq V
Breast Cancer Res Treat; 2010 Dec; 124(3):599-605. PubMed ID: 19779817
[TBL] [Abstract][Full Text] [Related]
14. Reliability of whole sentinel lymph node analysis by one-step nucleic acid amplification for intraoperative diagnosis of breast cancer metastases.
Castellano I; Macrì L; Deambrogio C; Balmativola D; Bussone R; Ala A; Coluccia C; Sapino A
Ann Surg; 2012 Feb; 255(2):334-42. PubMed ID: 21975319
[TBL] [Abstract][Full Text] [Related]
15. Markers of progression and invasion in short term follow up of untreated breast cancer patients.
Rabi ZA; Todorović-Raković N; Vujasinović T; Milovanović J; Nikolić-Vukosavljević D
Cancer Biomark; 2015; 15(6):745-54. PubMed ID: 26406416
[TBL] [Abstract][Full Text] [Related]
16. Predicting the likelihood of additional nodal metastases in breast carcinoma patients with positive sentinel node biopsy.
Mustać E; Matusan-Ilijas K; Marijić B; Smokvina M; Jonjić N
Int J Surg Pathol; 2010 Feb; 18(1):36-41. PubMed ID: 19448065
[TBL] [Abstract][Full Text] [Related]
17. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of ERM gene expression in human primary breast cancers.
Chotteau-Lelièvre A; Révillion F; Lhotellier V; Hornez L; Desbiens X; Cabaret V; de Launoit Y; Peyrat JP
Clin Cancer Res; 2004 Nov; 10(21):7297-303. PubMed ID: 15534105
[TBL] [Abstract][Full Text] [Related]
19. Histopathologic analysis of sentinel lymph nodes in breast carcinoma.
Hsieh PP; Ho WL; Yeh DC; Liu TJ; Wu CC; Lin JH; Wang SJ
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):744-50. PubMed ID: 11076431
[TBL] [Abstract][Full Text] [Related]
20. Factors predicting non-sentinel lymph node metastasis in T1-2 invasive breast cancer with 1-2 axillary sentinel lymph node metastases: Presentation of Ondokuz Mayis scoring system.
Kuru B; Sullu Y; Yuruker S; Koray Bayrak I; Ozen N
J BUON; 2016; 21(5):1129-1136. PubMed ID: 27837614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
